Kyle E. Allen, Ph.D.
Affiliations: | 2010 | University of Washington, Seattle, Seattle, WA |
Area:
Pharmacy, Physiology BiologyGoogle:
"Kyle Allen"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Kent L. Kunze | grad student | 2010 | University of Washington | |
| (Kinetics of sequentially metabolized suicide substrates: Theoretical and practical aspects of metabolic intermediate complex formation in rat cytochrome P450 2C11 metabolism of desipramine.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Totah RA, Allen KE, Sheffels P, et al. (2007) Enantiomeric metabolic interactions and stereoselective human methadone metabolism. The Journal of Pharmacology and Experimental Therapeutics. 321: 389-99 |
| Cameron MD, Wen B, Allen KE, et al. (2005) Cooperative binding of midazolam with testosterone and alpha-naphthoflavone within the CYP3A4 active site: a NMR T1 paramagnetic relaxation study. Biochemistry. 44: 14143-51 |
| McConn DJ, Lin YS, Allen K, et al. (2004) Differences in the inhibition of cytochromes P450 3A4 and 3A5 by metabolite-inhibitor complex-forming drugs. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 32: 1083-91 |
| Isoherranen N, Kunze KL, Allen KE, et al. (2004) Role of itraconazole metabolites in CYP3A4 inhibition. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 32: 1121-31 |